Advertisement
Research ArticleCardiovascular

PHARMACOLOGICAL CHARACTERIZATION OF APROCITENTAN, A DUAL ENDOTHELIN RECEPTOR ANTAGONIST, ALONE AND IN COMBINATION WITH BLOCKERS OF THE RENIN ANGIOTENSIN SYSTEM, IN TWO MODELS OF EXPERIMENTAL HYPERTENSION

Frederic Trensz, Celine Bortolamiol, Markus Kramberg, Daniel Wanner, Hakim Hadana, Markus Rey, Daniel S Strasser, Stephane Delahaye, Patrick Hess, Enrico Vezzali, Ulrich Mentzel, Joel Menard, Martine Clozel and Marc Iglarz
Journal of Pharmacology and Experimental Therapeutics January 8, 2019, jpet.118.253864; DOI: https://doi.org/10.1124/jpet.118.253864
Compose eLetter

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.
Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools
Research ArticleCardiovascular

PHARMACOLOGICAL CHARACTERIZATION OF APROCITENTAN, A DUAL ENDOTHELIN RECEPTOR ANTAGONIST, ALONE AND IN COMBINATION WITH BLOCKERS OF THE RENIN ANGIOTENSIN SYSTEM, IN TWO MODELS OF EXPERIMENTAL HYPERTENSION

Frederic Trensz, Celine Bortolamiol, Markus Kramberg, Daniel Wanner, Hakim Hadana, Markus Rey, Daniel S Strasser, Stephane Delahaye, Patrick Hess, Enrico Vezzali, Ulrich Mentzel, Joel Menard, Martine Clozel and Marc Iglarz
Journal of Pharmacology and Experimental Therapeutics January 8, 2019, jpet.118.253864; DOI: https://doi.org/10.1124/jpet.118.253864
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Jump to section

Advertisement